Ensuring mRNA stability and translation efficiency
Scalable production of high-purity mRNA
Optimizing LNP formulations for effective delivery
Sequence Optimization and Immunogenicity Control
High-yield, cap-modified mRNA with modified nucleotides for enhanced stability and reduced immunogenicity.
Self-amplifying and circular RNA constructs for prolonged antigen expression and dose-sparing.
Lipid nanoparticle encapsulation optimized for mRNA delivery and immunogenicity.
Deep experience in both research-grade and GMP-ready mRNA production.
Rapid prototyping and scalable manufacturing to support preclinical through clinical stages.
From sequence to formulated product, simplifying your supply chain.
Access to novel technologies like circRNA and saRNA.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
